jobs.jnj.com/en/jobs/
Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Our Businesses
Explore more Johnson & Johnson sites:
Switzerland
A colorful graphic with people standing in front of charts and graphs alt
Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
64
Latest News

What You Need to Know About Johnson & Johnson's 2022 Fourth-Quarter and Full-Year Earnings Report

Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
64
Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
Today's Top Reads Close
Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
64
expand

Today, Johnson & Johnson shared its 2022 fourth-quarter and full-year earnings report.

Since its founding in 1886, the company has grown to become one of the world's largest and most broadly based healthcare companies, with 144,000 employees across the globe working every day to help change the trajectory of health for humanity.

“Johnson & Johnson delivered solid results and demonstrated competitive growth across our business segments in 2022, while managing ongoing macroeconomic challenges," says Joe Wolk Circular image Joseph J. WolkExecutive Vice President and Chief Financial Officer, Johnson & Johnson, Executive Vice President and Chief Financial Officer, Johnson & Johnson. "We are particularly proud of the pipeline and portfolio advancements in our Pharmaceutical and MedTech businesses as well as the continued progress toward the planned separation of our Consumer Health business, all of which will fortify the foundation for long-term value creation."

For more details about the company's 2022 fourth-quarter and full-year results, and to read a message from Chairman of the Board and Chief Executive Officer Joaquin Duato Circular image Joaquin DuatoChairman of the Board and Chief Executive Officer, Johnson & Johnson, here's an infographic highlighting key stats.


Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
64
expand

Read the earnings press release, which includes fourth-quarter and full-year financial data for 2022.

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
64

More from Johnson & Johnson

Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue